Zevin Asset Management LLC Boosts Stock Position in Danaher Co. (NYSE:DHR)

Share on StockTwits

Zevin Asset Management LLC boosted its holdings in Danaher Co. (NYSE:DHR) by 1.2% during the 3rd quarter, Holdings Channel reports. The firm owned 67,015 shares of the conglomerate’s stock after acquiring an additional 768 shares during the period. Danaher makes up about 3.1% of Zevin Asset Management LLC’s investment portfolio, making the stock its 11th largest holding. Zevin Asset Management LLC’s holdings in Danaher were worth $9,679,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. boosted its position in Danaher by 1.4% in the second quarter. Vanguard Group Inc. now owns 48,262,218 shares of the conglomerate’s stock worth $6,897,635,000 after purchasing an additional 686,421 shares during the last quarter. Northern Trust Corp lifted its position in shares of Danaher by 0.5% during the 2nd quarter. Northern Trust Corp now owns 8,929,430 shares of the conglomerate’s stock valued at $1,276,194,000 after buying an additional 41,740 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Danaher by 3.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,753,246 shares of the conglomerate’s stock valued at $822,255,000 after buying an additional 188,752 shares during the last quarter. Jennison Associates LLC lifted its position in shares of Danaher by 38.4% during the 2nd quarter. Jennison Associates LLC now owns 5,135,358 shares of the conglomerate’s stock valued at $733,945,000 after buying an additional 1,424,328 shares during the last quarter. Finally, Parnassus Investments CA lifted its position in shares of Danaher by 1.2% during the 3rd quarter. Parnassus Investments CA now owns 4,772,773 shares of the conglomerate’s stock valued at $689,332,000 after buying an additional 54,323 shares during the last quarter. 78.30% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have recently commented on DHR shares. Wolfe Research set a $154.00 price target on Danaher and gave the company a “buy” rating in a research report on Friday, October 25th. Piper Jaffray Companies upped their price target on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Robert W. Baird upped their price target on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Needham & Company LLC dropped their price target on Danaher from $155.00 to $152.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, ValuEngine cut Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Danaher presently has an average rating of “Buy” and an average target price of $145.86.

DHR traded up $0.73 during trading on Friday, reaching $135.23. 1,633,369 shares of the company were exchanged, compared to its average volume of 2,487,994. The company’s 50-day moving average is $139.07 and its two-hundred day moving average is $138.28. The company has a market cap of $95.87 billion, a price-to-earnings ratio of 29.92, a P/E/G ratio of 2.24 and a beta of 0.92. The company has a quick ratio of 3.09, a current ratio of 3.43 and a debt-to-equity ratio of 0.52. Danaher Co. has a 12-month low of $94.59 and a 12-month high of $147.33.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.15 by $0.01. The business had revenue of $5.04 billion for the quarter, compared to analysts’ expectations of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.10 EPS. Equities analysts forecast that Danaher Co. will post 4.76 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a dividend of $0.17 per share. The ex-dividend date was Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a yield of 0.50%. Danaher’s dividend payout ratio (DPR) is 15.04%.

In related news, Chairman Mitchell P. Rales acquired 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were acquired at an average price of $139.52 per share, with a total value of $348,800.00. Following the acquisition, the chairman now owns 3,030,453 shares of the company’s stock, valued at approximately $422,808,802.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.40% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: What is the G-20?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zevin Asset Management LLC Sells 4,340 Shares of GlaxoSmithKline plc
Zevin Asset Management LLC Sells 4,340 Shares of GlaxoSmithKline plc
Zevin Asset Management LLC Boosts Stock Position in Danaher Co.
Zevin Asset Management LLC Boosts Stock Position in Danaher Co.
Fiduciary/Claymore Energy Infrstrctr Fnd  Shares Sold by Parkside Financial Bank & Trust
Fiduciary/Claymore Energy Infrstrctr Fnd Shares Sold by Parkside Financial Bank & Trust
Reinhart Partners Inc. Reduces Position in KAR Auction Services Inc
Reinhart Partners Inc. Reduces Position in KAR Auction Services Inc
iShares Russell Mid-Cap Growth ETF  Shares Sold by Whitnell & Co.
iShares Russell Mid-Cap Growth ETF Shares Sold by Whitnell & Co.
Triodos Investment Management BV Has $2.10 Million Position in Universal Display Co.
Triodos Investment Management BV Has $2.10 Million Position in Universal Display Co.


 
© 2006-2019 Zolmax.